nuvoteQ to be a Premier Sponsor of ACDM22
Date: August 23, 2021
The Association for Clinical Data Management is delighted to announce that nuvoteQ are to be a Premier Sponsor of ACDM22.
nuvoteQ is an African based software company specialising in secure cloud-based platforms used in the conduct of clinical research. The company aims to provide world class solutions at a price which is affordable for 3rd world countries to use. nuvoteQ believe that solutions should be completely configurable through the front-end while still maintaining strong technical cohesiveness in the back-end. They follow the design principle of the “lego block” and ensure that all new features of their respective product stacks are totally inter-operable and compatible with each other.
ACDM22 is the 2022 Annual Conference of the Association for Clinical Data Management and is being held in Edinburgh, Scotland, from the 13th-15th March 2022.
Explore More News

Launch of Online Training from ACDM
The Association for Clinical Data Management is delighted to announce the launch of Online . . .
Read More

ACDM 2019 Awards Finalists
The Association for Clinical Data Management are delighted to announce the finalists for . . .
Read More

Castor EDC to Sponsor ACDM19
The Association for Clinical Data Management (ACDM) are delighted to announce that Castor . . .
Read More

Danone Nutricia Research to Sponsor ACDM19
The Association for Clinical Data Management (ACDM) are delighted to announce that . . .
Read More

ACDM19 Conference Programme
The Association for Clinical Data Management is delighted to announce the Full Programme . . .
Read More

Record Number of Abstracts Submitted for ACDM19
The deadline for Abstracts for ACDM19 passed on the 30th September and the Association for . . .
Read More

Phastar Sponsor ACDM19
The Association for Clinical Data Management are delighted to announce that PHASTAR are . . .
Read More

Launch of Annual ACDM Awards
The Association for Clinical Data Management are delighted to announce the introduction of . . .
Read More